Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years

The objectives of this study are:

1. to determine the degree of understanding and perceived risks for human papillomavirus (HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and identify potential barriers to HPV vaccine access and utilization in a population of young men who have sex with men (MSM) (under 26 years of age)and in parents of boys aged 9 to 18 years 2. to determine HPV vaccine acceptance and predictors of acceptance in a population of young MSM and in patients of boys ages 9 to 18 years 3. to develop strategies to overcome potential barriers to vaccination and improve vaccine access and utilization via development of targeted educational initiatives.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Human Papillomavirus (HPV)

Age range

9 year–26 year

Sex eligibility

Male

Study type

Observational

Primary location

Children's Memorial Hospital Uptown Clinic, Chicago, Illinois, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

MSM group - under age 26 years
Parent group - parent of boy(s) ages 9 to 18 years

Exclusion criteria

MSM group - previous receipt of HPV vaccine
Parent group - previous receipt of HPV vaccine by male child

Treatment and study plan

Survey

Other

Self administered anonymous survey

Sponsors and collaborators

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Other

Registry information

Important dates

Study start: 2010
Primary completion: 2013
Study completion: 2016
First posted: Sep 9, 2010
Registry last updated: Mar 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed